Talking Transplant
Claim This Podcastby Takeda
Podcast Overview
<p>Welcome to Talking Transplant! </p><h6><br></h6><p>Throughout this podcast our expert host and guests will discuss topics in transplant that go beyond the every-day. </p><h6><br></h6><p>Listen to the first episode where Dr Annemarie Wei<strong>ß</strong>enbacher (Austria) and Dr Mark Harber (UK) discuss the principles of sustainable healthcare for transplants and explore improvement opportunities in long-term sustainability of transplant care and empower the medical community to take action. </p><br><p>Listen to the second episode where Dr Annemarie Weißenbacher and Dr Deepali Kumar (Canada) raise awareness of infectious complications throughout the transplant journey, and the risks that they may pose to patients undergoing both solid organ and haematopoietic stem cell procedures.</p><p><br></p><h6>All information is accurate as of September 2024. This podcast is intended for HCPs outside of the USA. This podcast is initiated, organised and funded by Takeda. Speakers were paid an honorarium by Takeda for their participation. Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited.</h6><h6><br></h6><h6>Episode 1: Date of prep: September 2024; VV-MEDMAT-72907; VV-MEDAT-73823.</h6><h6>Episode 2: Date of prep: July 2024; VV-MEDMAT-105917.</h6><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
Language
🇺🇲
Publishing Since
7/8/2024
1 verified contact email on file for Talking Transplant
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 8, 2024
Infections throughout the transplant journey
<p>Listen to the second episode of the Talking Transplant podcast, where Dr Annemarie Weißenbacher (Austria) and Dr Deepali Kumar (Canada) raise awareness of infectious complications throughout the transplant journey, and the risks that they may pose to patients undergoing both solid organ and haematopoietic stem cell procedures. </p><p> </p><p>All information is accurate as of July 2024. This podcast is intended for HCPs outside of the USA. This podcast is initiated, organised and funded by Takeda. Speakers were paid an honorarium by Takeda for their participation. Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited. Date of prep: July 2024; VV-MEDMAT-105917</p><br /><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p>
1 total episodes available
Deep-dive analytics for Talking Transplant
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Talking Transplant?
<p>Welcome to Talking Transplant! </p><h6><br></h6><p>Throughout this podcast our expert host and guests will discuss topics in transplant that go beyond the every-day. </p><h6><br></h6><p>Listen to the first episode where Dr Annemarie Wei<strong>ß</strong>enbacher (Austria) and Dr Mark Harber (UK) discuss the principles of sustainable healthcare for transplants and explore improvement opportunities in long-term sustainability of transplant care and empower the medical community to take action. </p><br><p>Listen to the second episode where Dr Annemarie Weißenbacher and Dr Deepali Kumar (Canada) raise awareness of infectious complications throughout the transplant journey, and the risks that they may pose to patients undergoing both solid organ and haematopoietic stem cell procedures.</p><p><br></p><h6>All information is accurate as of September 2024. This podcast is intended for HCPs outside of the USA. This podcast is initiated, organised and funded by Takeda. Speakers were paid an honorarium by Takeda for their participation. Copyright 2024 Takeda Pharmaceutical Company Limited. All rights reserved. Takeda and the Takeda logo are registered trademarks of Takeda Pharmaceutical Company Limited.</h6><h6><br></h6><h6>Episode 1: Date of prep: September 2024; VV-MEDMAT-72907; VV-MEDAT-73823.</h6><h6>Episode 2: Date of prep: July 2024; VV-MEDMAT-105917.</h6><hr><p style='color:grey; font-size:0.75em;'> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.</p> - How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.